Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for PGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 94.32%
March 31, 2026 87.63%
December 31, 2025 58.07%
September 30, 2025 53.70%
June 30, 2025 -64.72%
March 31, 2025 -5.82%
December 31, 2024 -24.96%
September 30, 2024 -39.24%
June 30, 2024 -209.9%
March 31, 2024 -76.10%
December 31, 2023 -109.0%
September 30, 2023 -71.32%
June 30, 2023 -43.94%
March 31, 2023 -28.71%
December 31, 2022 -37.15%
September 30, 2022 83.69%
June 30, 2022 -51.87%
March 31, 2022 51.88%
December 31, 2021 22.26%
September 30, 2021 16.98%
June 30, 2021 -8.47%
March 31, 2021 47.06%
December 31, 2020 28.67%
September 30, 2020 44.08%
June 30, 2020 50.99%
Date Value
March 31, 2020 54.34%
December 31, 2019 9.36%
September 30, 2019 21.00%
June 30, 2019 49.08%
March 31, 2019 34.41%
December 31, 2018 66.03%
September 30, 2018 52.77%
June 30, 2018 59.06%
March 31, 2018 65.07%
December 31, 2017 80.06%
September 30, 2017 67.37%
June 30, 2017 69.05%
March 31, 2017 70.58%
December 31, 2016 69.11%
September 30, 2016 69.46%
June 30, 2016 67.46%
March 31, 2016 64.93%
December 31, 2015 63.95%
September 30, 2015 68.77%
June 30, 2015 59.31%
March 31, 2015 58.53%
December 31, 2014 47.96%
September 30, 2014 54.54%
June 30, 2014 0.00%
March 31, 2014 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Geron Corp. 94.94%
Elicio Therapeutics, Inc. --
Agenus, Inc. 98.50%
Amgen, Inc. 72.08%
Anika Therapeutics, Inc. 65.15%

Gross Profit Margin (Quarterly) Related Metrics